800-826-HOPE (4673)
If you've been diagnosed with lymphoma or looking for a second opinion, you and your family may be facing a lot of difficult questions. City of Hope's lymphoma specialists can walk you through the treatment process, address your concerns, and create a personalized plan designed to give you the best possible results.
 

Why Choose Us

At the Toni Stephenson Lymphoma Center at City of Hope, we bring together lymphoma treatment and research expertise from multiple disciplines with an unmatched reputation for coordinated, compassionate care:
  • State-of-the-art diagnostic tools.
  • Pioneering drug research and clinical trials.
  • Unique chemotherapy, immunotherapy, radiation, adoptive T cell therapy and stem cell transplant options.
  • Exceptional patient and family supportive care and survivorship programs.

Top Ranked Cancer Center

  • Recognized internationally for research and breakthrough treatments of lymphoma.
  • Our Hematologic Malignancies and Stem Cell Transplantation Institute is also one of the largest transplant centers in the country, producing some of the consistently best outcomes.
  • Designated a Comprehensive Cancer Center by the National Cancer Institute.
  • Named by U.S. News & World Report as one of America's top cancer hospitals for over a decade.

Request a Consultation

If you have been diagnosed with lymphoma or are looking for a second opinion consultation about your treatment, request an appointment online or contact us at 800-826-HOPE. Please visit Making Your First Appointment for more information.

Learn More About Lymphomas

 

Care Team

City of Hope’s renowned physicians and researchers utilize the latest in technology and innovation to treat lymphoma, coupled with our enduring belief in providing unparalleled compassionate care.

Anatomical and Clinical Pathology

Patricia Aoun, M.D., M.P.H.

Clinical Specialties

  • Anatomical and Clinical Pathology

Anatomic and Clinical Pathology

Michelle Afkhami, M.D.

Clinical Specialties

  • Anatomic and Clinical Pathology
  • Molecular Pathology
  • Hematopathology
Young Kim, M.D.

Clinical Specialties

  • Anatomic and Clinical Pathology
Joo Y. Song, M.D.

Clinical Specialties

  • Anatomic and Clinical Pathology
Dennis Dean Weisenburger, M.D.

Clinical Specialties

  • Anatomic and Clinical Pathology

Dermatopathology

Christiane Querfeld, M.D., Ph.D.

Clinical Specialties

  • Dermatopathology
  • Dermatology

Hematologic Malignancies

Ryotaro Nakamura, M.D.

Clinical Specialties

  • Hematologic Malignancies
  • Lymphoma
  • Leukemia
  • Myelodysplastic Syndrome
  • Aplastic Anemia

Hematology/Oncology

Elizabeth Budde, M.D., Ph.D.

Clinical Specialties

  • Hematology/Oncology
Robert W. Chen, M.D.

Clinical Specialties

  • Hematology/Oncology
Stephen J. Forman, M.D., F.A.C.P.

Clinical Specialties

  • Hematology/Oncology
Alex Herrera, M.D.

Clinical Specialties

  • Hematology/Oncology
Alexandra Levine, M.D., M.A.C.P.

Clinical Specialties

  • Hematology/Oncology
Auayporn Nademanee, M.D.

Clinical Specialties

  • Hematology/Oncology
Steven T. Rosen, M.D.

Clinical Specialties

  • Hematology/Oncology
Tanya Siddiqi, M.D.

Clinical Specialties

  • Hematology/Oncology
Jasmine M Zain, M.D.

Clinical Specialties

  • Hematology/Oncology

Hematology/Oncology/Internal Medicine

Leslie L Popplewell, M.D., F.A.C.P.

Clinical Specialties

  • Hematology/Oncology/Internal Medicine

Medical Oncology

Larry W. Kwak, M.D.,Ph.D.

Clinical Specialties

  • Medical Oncology

Pathology

Raju K. Pillai, M.D.

Clinical Specialties

  • Pathology

Radiation Oncology

Jeffrey Y.C. Wong, M.D.

Clinical Specialties

  • Radiation Oncology

Research Pathology

John Chan, M.D.

Clinical Specialties

  • Research Pathology
  • Hematopathology
Ben Teller Success Story Image
Ben, lymphoma survivor

"The moment I entered the doors of City of Hope, I felt like a person again."

Christine Pechera Success Story Image
Christine, lymphoma survivor

"There’s a humanity that exists on this campus that you can’t find in other hospitals."

Every patient is different, with different needs. At City of Hope's Hematologic Malignancies and Stem Cell Transplantation Institute, we treat you as a valued individual. Our entire team works together to bring you precise, state-of-the-art treatment options that will deliver the best outcome for you. We support you every step of the way, both during treatment and long after, helping you and your loved ones manage your recovery.
 
Learn more about our treatment options for lymphoma including:

 

 

City of Hope is a recognized leader in lymphoma research. We offer access to dozens of clinical trials and new therapies not always available elsewhere. Our latest research ranges from identifying better drugs that help prevent relapses, to more effective and less toxic chemotherapy agents, as well as groundbreaking procedures for patients with both lymphoma and HIV.
 
Browse through some of our clinical trials and research projects here.
 

  • Phase I Study of Yttrium-90 Labeled Anti-CD25 (a-Tac) Monoclonal Antibody Plus BEAM for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients with Primary Refractory or Relapsed Hodgkin Lymphoma, the "a-Tac BEAM Regimen"
  • A Phase II Clinical Trial of MK-3475 (Pembrolizumab) in Subjects with Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
  • A Phase 2, Open-Label Study of the Safety and Efficacy of INCB040093 and INCB040093 Combined With INCB039110 in Subjects With Relapsed or Refractory Hodgkin Lymphoma
  • A Multi-Center Open-Label Study of the Bruton’s Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with MEDI4736, in Subjects with Relapsed or Refractory Lymphomas
  • A Phase 2 Open Label Study to Investigate the Efficacy of Autologous EBV-Specific T-Cells for the Treatment of Patients with Agreessive Extranodal NK/T Cell Lymphoma (ENKTCL)
  • A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination with Either Bendamustine and Rituximab (BR) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednis
  • An Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine administered in Patients with B-cell Non-Hodgkin Lymphoma (NHL)
  • SWOG S1001: A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL)
  • When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your family take each step in your lymphoma journey. We can help with all of these concerns, and more:
    • Managing side effects
    • Pain management
    • Navigating the health care system
    • Your emotional, social and spiritual health
    • Staying healthy and active
    • Healthy cooking and eating
    • Healing arts
    • Caregiver skills
    • Dealing with family, school or work stress
    Learn more about these resources at our Living with Cancer or Supportive Care Medicine sites.
     
     
     

    SUPPORT THE TONI STEPHENSON LYMPHOMA CENTER

     

    We deliver exquisite care at the leading edge of lymphoma cancer treatment. It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts over 100 years ago. Their efforts - and those of our supporters today - have built the foundation for the care we provide and the research we conduct.

    DONATE ONLINE TO THE TONI STEPHENSON LYMPHOMA CENTER

    For more information on supporting the lymphoma program, please contact:
     

    Amy M. Cook, Ph.D.
    Associate Director, Philanthropy
    Direct: 626-218-6228
     

     

    City of Hope experts cover lymphoma screening, treatment, research and other cancer topics on City of Hope’s Breakthrough’s blog.

    Back To Top